title: Frequency of seborrheic keratosis biopsies in the United States: a benchmark of skin lesion care quality and cost effectiveness.
abstract: BACKGROUND
  Most seborrheic keratoses may be readily clinically differentiated from skin cancer, but occasional lesions resemble atypical melanocytic neoplasms.
  
  
  OBJECTIVE
  To evaluate the frequency, cost, and intensity of procedures performed that result in the removal and histopathologic evaluation of seborrheic keratoses.
  
  
  METHODS
  Episodes of surgical removal of lesions that were identified as seborrheic keratoses by histologic identification were determined using Medicare Current Beneficiary Survey data from 1998 to 1999. These episodes were defined by a histopathology procedure code that is associated with a diagnosis code for seborrheic keratosis. We then identified what procedure(s) generated the histopathology specimen. Biopsy and shave procedures were considered "low intensity," whereas excision and repair procedures were considered "high intensity."
  
  
  RESULTS
  Dermatologists managed 85% of all episodes of seborrheic keratoses. Dermatologists managed 89% of seborrheic keratosis episodes using low-intensity procedures compared with 51% by other specialties. For nondermatologists, 46% of the treatment cost (9 million US dollars) to Medicare was generated from high-intensity management compared with 15% by dermatologists (6 million US dollars).
  
  
  CONCLUSIONS
  There is a significant difference in the management of suspicious pigmented lesions between dermatologists and other specialists. This affects both the cost and quality of care.
authors.affiliation: Center for Dermatology Research, Department of Dermatology at Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
authors.forename: Maria I
authors.initials: MI
authors.lastname: Duque
authors.forename: J Ryan
authors.initials: JR
authors.lastname: Jordan
authors.forename: Alan B
authors.initials: AB
authors.lastname: Fleischer
authors.forename: Phillip M
authors.initials: PM
authors.lastname: Williford
authors.forename: Steven R
authors.initials: SR
authors.lastname: Feldman
authors.forename: Hoa
authors.initials: H
authors.lastname: Teuschler
authors.forename: G John
authors.initials: GJ
authors.lastname: Chen
mesh_terms: D019985:Benchmarking; D001706:Biopsy / Q000191:economics / Q000706:statistics & numerical data; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003880:Dermatology; D006801:Humans; D017492:Keratosis, Seborrheic / Q000191:economics / Q000473:pathology* / Q000601:surgery; D006278:Medicare / Q000191:economics / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000706:statistics & numerical data*; D014481:United States